MDT - Medtronic plc

NYSE - NYSE Delayed Price. Currency in USD
92.33
+0.06 (+0.07%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close92.27
Open93.22
Bid91.50 x 800
Ask92.97 x 900
Day's Range92.23 - 94.59
52 Week Range76.41 - 100.15
Volume6,891,817
Avg. Volume6,078,872
Market Cap123.777B
Beta (3Y Monthly)0.57
PE Ratio (TTM)57.92
EPS (TTM)1.59
Earnings DateAug 17, 2015 - Aug 21, 2015
Forward Dividend & Yield2.00 (2.19%)
Ex-Dividend Date2018-12-27
1y Target Est102.10
Trade prices are not sourced from all markets
  • Medtronic Announces Cash Tender Offer for Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.
    GlobeNewswire22 minutes ago

    Medtronic Announces Cash Tender Offer for Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.

    DUBLIN - February 20, 2019 - Medtronic plc (the "Company") (NYSE: MDT) today announced the commencement of a cash tender offer by its indirectly wholly owned subsidiaries, Medtronic, Inc. ("Medtronic, ...

  • The Wall Street Journal9 hours ago

    [$$] Medtronic Swings to Profit Despite Slowdown in Heart-Failure Treatments

    Higher sales of medical devices used in the treatment of brain and kidney diseases helped Medtronic PLC offset a slowdown in sales of gear for heart conditions in its latest quarter. Shares of Medtronic rose 0.5% after the biggest stand-alone medical-device company by sales reported improved revenue and earnings for its fiscal third quarter ended Jan. 25. Medtronic Chief Executive Omar Ishrak said in an interview that the medical-device market is healthy, and the company’s diversified business model helped it post sales and earnings growth despite downturns in some areas.

  • IntriCon Corp (IIN) Q4 2018 Earnings Conference Call Transcript
    Motley Fool9 hours ago

    IntriCon Corp (IIN) Q4 2018 Earnings Conference Call Transcript

    IIN earnings call for the period ending December 31, 2018.

  • Medtronic (MDT) Q3 2019 Earnings Conference Call Transcript
    Motley Fool12 hours ago

    Medtronic (MDT) Q3 2019 Earnings Conference Call Transcript

    MDT earnings call for the period ending January 25, 2019.

  • Medical Giant Beats Quarterly 'Doom And Gloom' — Inches Toward Breakout
    Investor's Business Daily12 hours ago

    Medical Giant Beats Quarterly 'Doom And Gloom' — Inches Toward Breakout

    Medtronic stock inched closer to a breakout Tuesday after its fiscal third quarter earnings topped expectations, though sales from diabetes products lagged estimates.

  • TheStreet.com13 hours ago

    Dow Closes Higher as Wall Street Looks to Next Round of Trade Talks

    Stocks edger higher Tuesday as investors look to a key round of trade talks between the U.S. and China.

  • Thomson Reuters StreetEvents13 hours ago

    Edited Transcript of MDT earnings conference call or presentation 19-Feb-19 1:00pm GMT

    Q3 2019 Medtronic PLC Earnings Call

  • Medtronic Rises on 3rd-Quarter Results for Fiscal 2019
    GuruFocus.com16 hours ago

    Medtronic Rises on 3rd-Quarter Results for Fiscal 2019

    The Irish health care major topped consensus on earnings and revenues

  • Medtronic Earnings: MDT Reports Q3 Earnings Beat
    InvestorPlace16 hours ago

    Medtronic Earnings: MDT Reports Q3 Earnings Beat

    The Medtronic earnings report for the company's fiscal third quarter of 2019 is out.Source: Shutterstock Medtronic (NYSE:MDT) reported earnings per share of $1.29 for its fiscal third quarter of the year. This is up from the company's earnings per share of $1.17 from its fiscal third quarter of 2018. It also beat out Wall Street's earnings per share estimate of $1.24 for its fiscal third quarter of 2019.Medtronic earnings for its fiscal third quarter of the year also includes net income of $1.27 billion. This is an increase over the company's net loss of $1.39 billion reported in the same period of the year prior.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe Medtronic earnings report for the company's fiscal third quarter of 2019 also has operating income coming in at $1.54 billion. The medical device company reported operating income of $1.44 billion in its fiscal third quarter of the previous year.Revenue reported in the Medtronic earnings release for its fiscal third quarter of the year was $7.55 billion. This is better than the company's revenue of $7.37 billion reported during the same time last year. It also comes in above analysts' revenue estimate of $7.52 billion for the period. * 7 Financial Stocks With Accelerating Growth "Revenue outperformance in our Minimally Invasive Therapies and Restorative Therapies Groups, as well as broad strength across Emerging Markets, helped to offset certain market-specific headwinds we faced during the quarter, reflecting the full benefits of our diversification," Omar Ishrak, Chairman and CEO of Medtronic, said in a statement.MDT stock was up slightly as of noon Monday. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Hot Stocks Leading the Market's Blitz Higher * 7 Strong Buy Stocks With Over 20% Upside * 5 Growthy Stocks Trading Below 15X Earnings As of this writing, William White did not hold a position in any of the aforementioned securities.Compare Brokers The post Medtronic Earnings: MDT Reports Q3 Earnings Beat appeared first on InvestorPlace.

  • Reuters17 hours ago

    US STOCKS-Wall St flat as Walmart offsets bank losses; trade talks eyed

    U.S. stocks struggled for direction on Tuesday as gains in Walmart offset losses in financials, with trade talks between the United States and China in focus. The S&P index recorded 29 new 52-week highs and no new lows, while the Nasdaq recorded 68 new highs and 17 new lows.

  • Medtronic quarterly profit beats on strength in surgical products
    Reuters17 hours ago

    Medtronic quarterly profit beats on strength in surgical products

    The company has been building its minimally invasive and robotic surgery device businesses through acquisitions to make up for slowing growth in its top-earning unit that makes stents and heart pumps. The minimally invasive therapies business, which makes surgical instruments such as those used to treat hernias and kidney disease, brought in revenue of $2.12 billion in the third quarter, above estimates of $2.08 billion.

  • Medtronic Reported Earnings Above Positive Charts
    Investopedia18 hours ago

    Medtronic Reported Earnings Above Positive Charts

    Medtronic stock has positive technicals, but the upside for 2019 will likely be limited to the annual risky level at $100.62.

  • Stock Market News: Wal-Mart Sees E-Commerce Growth, Medtronic Looks Healthy
    Motley Fool18 hours ago

    Stock Market News: Wal-Mart Sees E-Commerce Growth, Medtronic Looks Healthy

    Despite some crosscurrents in the overall market, earnings remained generally favorable.

  • Walmart & Medtronic Report Earnings
    Zacks18 hours ago

    Walmart & Medtronic Report Earnings

    Walmart & Medtronic Report Earnings

  • Medtronic (MDT) Beats on Q3 Earnings, Gross Margin Down
    Zacks18 hours ago

    Medtronic (MDT) Beats on Q3 Earnings, Gross Margin Down

    Medtronic (MDT) demonstrates improved performances at CER based on growth in most of the business segments and all geographies.

  • Data Slows as Q4 Wanes; Walmart (WMT) Tops Estimates
    Zacks19 hours ago

    Data Slows as Q4 Wanes; Walmart (WMT) Tops Estimates

    The world's largest big-box retailer outperformed expectations on both its top and bottom lines for fiscal Q4: $1.41 per share surpassed the $1.33 in the Zacks consensus.

  • Reuters19 hours ago

    US STOCKS-Wall St subdued with U.S.-China trade talks in focus

    Hopes that the two countries will hammer out a deal to end their protracted trade war had helped the S&P 500 and the Nasdaq log their best week in a month on Friday. "We had a fairly good rally on Friday and there is a hint of profit-taking before the resumption of the trade talks," said Peter Cardillo, chief market economist at Spartan Capital Securities in New York. The consumer staples sector rose 0.40 percent, the most among the 11 major S&P sectors, helped by a 3.8 percent rise in shares of Walmart Inc.

  • Medtronic Posts Prelim PRODIGY Outcome on Opioid Overdose
    Zacks19 hours ago

    Medtronic Posts Prelim PRODIGY Outcome on Opioid Overdose

    The favorable PRODIGY study result by Medtronic (MDT) is undoubtedly a timely, strategic finding.

  • Medtronic (MDT)  Q3 Earnings Tops, Revenues Miss Estimates
    Zacks20 hours ago

    Medtronic (MDT) Q3 Earnings Tops, Revenues Miss Estimates

    Medtronic (MDT) gains on strength in the Minimally Invasive Therapies and Restorative Therapies Groups along with solid performance across emerging markets in Q3.

  • Reuters20 hours ago

    US STOCKS-Wall St set to open lower as U.S.-China trade talks resume

    U.S. stocks were set to dip at the open on Tuesday after rallying strongly last week, as investors focused on the latest round of trade talks between the United States and China. Hopes that the two countries will hammer out a deal to end their protracted trade war helped the S&P 500 and the Nasdaq log their best week in a month on Friday. "We had a fairly good rally on Friday and there is a hint of profit-taking before the resumption of the trade talks," said Peter Cardillo, chief market economist at Spartan Capital Securities in New York.

  • TheStreet.com21 hours ago

    Medtronic Reports Strong Surgical Product Sales on Way to Earnings Beat

    shares were up slightly Tuesday after the medical device maker reported third-quarter earnings and revenue ahead of analysts' expectations. "Our organization executed on multiple fronts to deliver a strong quarter for Medtronic," said Omar Ishrak, Medtronic chairman and chief executive officer. Medtronic shares are up about 3.3% year to date and have risen more than 10% over the past 12 months.

  • Associated Press22 hours ago

    Medtronic: Fiscal 3Q Earnings Snapshot

    Medtronic PLC (MDT) on Tuesday reported fiscal third-quarter net income of $1.27 billion, after reporting a loss in the same period a year earlier. On a per-share basis, the Dublin-based company said it ...

  • MarketWatch22 hours ago

    Medtronic beats profit and sales expectations

    Medtronic PLC reported fiscal third-quarter net income for the quarter to Jan. 25 that fell to $1.27 billion, or 94 cents a share, from $1.59 billion, or $1.17 a share, in the same period a year ago. Excluding non-recurring items, the medical technology company said adjusted earnings per share came to $1.29, above the FactSet consensus of $1.24. revenue rose 2.4% to $7.55 billion, just above the FactSet consensus of $7.53 billion, as U.S. revenue grew 2.3% to $4.00 billion. Non-U.S. developed market revenue rose 0.6% to $2.37 billion, while emerging market revenue increased 6.8% to $1.18 billion. For fiscal 2019, the company raised its adj. EPS outlook to $5.14 to $5.16 from $5.10 to $5.15 and its revenue growth forecast to 5.25% to 5.50% from 5.00% to 5.50%. The stock, which is still inactive in premarket trade, has gained 2.1% over the past three months while the S&P 500 has advanced 3.2%.

  • Medtronic Receives FDA Breakthrough Designation for Developing Personalized Closed Loop Insulin Pump System for Diabetes Management
    GlobeNewswire22 hours ago

    Medtronic Receives FDA Breakthrough Designation for Developing Personalized Closed Loop Insulin Pump System for Diabetes Management

    February 19, 2019 - Medtronic plc (MDT), the global leader in medical technology, today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Personalized Closed Loop (PCL) insulin pump system, currently in development. The system will also provide insights and predictive diagnostics unique to the individual, with a goal of dramatically simplifying diabetes management for the patient. The recent acquisition of Nutrino Health and their expertise in nutrition data science will play a key role in the accelerated development of this breakthrough technology.

  • Medtronic Reports Third Quarter Financial Results
    GlobeNewswire22 hours ago

    Medtronic Reports Third Quarter Financial Results

    Revenue of $7.5 Billion Increased 2.4% Reported; Increased 4.4% Organic  GAAP Diluted EPS of $0.94; Non-GAAP Diluted EPS of $1.29 Operating Margin of 20.4% Increased 90 bps; Non-GAAP Operating Margin of ...